# Federal Register #2026-21354

DEA notice on DMS Pharmaceutical Group’s application to import fentanyl for military use

**Buyer:** Drug Enforcement Administration
**Posted:** October 19, 2026
**Respond By:** November 19, 2026
**Identifier:** 2026-21354

This Department of Justice notice concerns DMS Pharmaceutical Group’s application to import fentanyl for military use.
- **Government agency:** U.S. Department of Justice, Drug Enforcement Administration (DEA); no sub-agency or office is identified.
- **Applicant:** DMS Pharmaceutical Group seeks DEA registration as an importer of fentanyl (drug code 9801, Schedule II).
- **Intended use:** DMS says the imported fentanyl would be distributed to military combat units.
- **Scope limits:** The proposed registration would not authorize other activities involving this drug code or imports of finished dosage forms for commercial sale.
- **Procurement status:** This is a regulatory application notice, not a solicitation or award. No purchase quantities, part numbers, contract value, or procurement services are provided.
- **OEMs:** No manufacturer or OEM is identified.

### Description

DMS Pharmaceutical Group applied to be registered as an importer of fentanyl (drug code 9801, Schedule II). The notice states that the company plans to import the controlled substance for distribution to military combat units, and that no other activity for this drug code is authorized under the registration. Registered bulk manufacturers of the affected substance and applicants may submit comments or objections, or request a hearing, by November 18, 2026.

[View original listing](https://www.federalregister.gov/documents/2026/10/19/2026-21354/importer-of-controlled-substances-application-dms-pharmaceutical-group)